We are live on ! Find out more
ENTA icon

Enanta Pharmaceuticals
ENTA

151 hedge funds and large institutions have $827M invested in Enanta Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 46 increasing their positions, 60 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 15

2% more funds holding

Funds holding: 148 → 151 (+3)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

3.14% less ownership

Funds ownership: 96.34% → 93.2% (-3.1%)

13% less capital invested

Capital invested by funds: $956M → $827M (-$129M)

23% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 60

73% less call options, than puts

Call options by funds: $897K | Put options by funds: $3.29M

Holders
151
Holders Change
+3
Holders Change %
+2.03%
% of All Funds
2.63%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
18
Increased
46
Reduced
60
Closed
15
Calls
$897K
Puts
$3.29M
Net Calls
-$2.39M
Net Calls Change
+$1.71M

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$17.2M
2
Millennium Management
Millennium Management
New York
+$5.72M
3
KAM
Krensavage Asset Management
New York
+$3.76M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.81M
5
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D
New Jersey
+$2.53M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$29.9M
2
CS
Candriam SCA
Luxembourg
-$7.24M
3
Renaissance Technologies
Renaissance Technologies
New York
-$5.02M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$4.74M
5
BlackRock
BlackRock
New York
-$2.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
SOADOR
76
State of Alaska Department of Revenue
Alaska
$547K +$13.8K +282 +2%
UBS AM
77
UBS AM
Illinois
$543K -$59.1K -1,206 -9%
HSBC Holdings
78
HSBC Holdings
United Kingdom
$529K +$583K +11,906 New
Public Employees Retirement Association of Colorado
79
Public Employees Retirement Association of Colorado
Colorado
$527K +$587K +11,982 New
Barclays
80
Barclays
United Kingdom
$495K -$604K -12,327 -52%
Manulife (Manufacturers Life Insurance)
81
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$493K +$3.18K +65 +0.6%
UBS Group
82
UBS Group
Switzerland
$485K -$745K -15,216 -58%
State of Tennessee, Department of Treasury
83
State of Tennessee, Department of Treasury
Tennessee
$466K -$9.79K -200 -2%
QI
84
QS Investors
New York
$463K – – –
VEA
85
Virtus ETF Advisers
New York
$461K -$208K -4,238 -29%
YMRC
86
Yorktown Management & Research Company
Virginia
$458K +$289K +5,900 +131%
AB
87
Amalgamated Bank
New York
$403K +$448K +9,153 New
ProShare Advisors
88
ProShare Advisors
Maryland
$401K +$31.7K +648 +8%
Jane Street
89
Jane Street
New York
$399K +$444K +9,060 New
FQ
90
First Quadrant
California
$397K – – –
SAM
91
Shell Asset Management
Netherlands
$392K +$23.5K +480 +6%
SFI
92
Susquehanna Fundamental Investments
Pennsylvania
$381K +$130K +2,652 +44%
JF
93
Jump Financial
Illinois
$370K +$411K +8,400 New
MIM
94
MetLife Investment Management
New Jersey
$365K – – –
IA
95
IndexIQ Advisors
New York
$361K -$7.2K -147 -2%
LSERS
96
Louisiana State Employees Retirement System
Louisiana
$356K -$4.9K -100 -1%
AQR Capital Management
97
AQR Capital Management
Connecticut
$351K -$10.2K -208 -3%
TI
98
Trexquant Investment
Connecticut
$350K +$390K +7,958 New
BNP Paribas Financial Markets
99
BNP Paribas Financial Markets
France
$330K -$15.5K -316 -4%
6M
100
6 Meridian
Kansas
$325K -$4.31K -88 -1%
2 3
4
5 6

ENTA Hedge Fund Activity: Q2 2021 in Review

151 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Enanta Pharmaceuticals (ENTA) for Q2 2021, worth a combined $827M — down 13% from $956M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new ENTA positions and 15 closed out — a net gain of 3 holders — while 46 added to existing stakes and 60 trimmed.

The largest buyer was Armistice Capital, adding an estimated $17.2M. The largest seller was T. Rowe Price Associates, cutting an estimated $29.9M.

  • 151 institutional investors held Enanta Pharmaceuticals (ENTA) as of Q2 2021, up from 148 in Q1 2021.
  • Funds reported $827M of Enanta Pharmaceuticals stock for Q2 2021, down 13% quarter-over-quarter.
  • 18 funds opened new Enanta Pharmaceuticals positions in Q2 2021 and 15 closed out, a net change of +3 holders.
  • The largest Enanta Pharmaceuticals buyer in Q2 2021 was Armistice Capital, an estimated $17.2M added.
  • The largest Enanta Pharmaceuticals seller in Q2 2021 was T. Rowe Price Associates, an estimated $29.9M sold.

Based on aggregated 13F filings for Q2 2021.